In vivo evaluation of the lysine‐specific demethylase (KDM1A/LSD1) inhibitor SP‐2577 (Seclidemstat) against pediatric sarcoma preclinical models: A report from the Pediatric Preclinical Testing Consortium (PPTC)
2019 ◽
2019 ◽
2005 ◽
Vol 25
(1_suppl)
◽
pp. S598-S598
◽
2005 ◽
Vol 25
(1_suppl)
◽
pp. S597-S597
2005 ◽
Vol 25
(1_suppl)
◽
pp. S595-S595
◽
Keyword(s):